(MMM) 3M - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US88579Y1010
Stock: Adhesives, Films, Safety, Cleaning, Electronics
Total Rating 52
Risk 76
Buy Signal -0.73
| Risk 5d forecast | |
|---|---|
| Volatility | 29.1% |
| Relative Tail Risk | -10.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.19 |
| Alpha | -12.19 |
| Character TTM | |
|---|---|
| Beta | 1.034 |
| Beta Downside | 1.409 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.87% |
| CAGR/Max DD | 1.11 |
EPS (Earnings per Share)
Revenue
Description: MMM 3M March 03, 2026
3M Company (NYSE: MMM) is a diversified industrial conglomerate headquartered in Saint Paul, Minnesota, operating globally through Safety and Industrial, Transportation and Electronics, and Consumer segments. Founded in 1902, the firm leverages core competencies in material sciences-specifically adhesives, films, and abrasives-to manufacture thousands of unique products for both industrial and retail markets. The Safety and Industrial division provides personal protective equipment, industrial adhesives, and electrical components, while the Transportation and Electronics segment supplies the automotive and semiconductor industries with display films and assembly solutions.
The Consumer segment markets home improvement goods, stationery, and personal health care items through extensive retail and e-commerce channels. 3M serves a broad range of sectors including energy, healthcare, and manufacturing, distributing products via direct sales, wholesalers, and distributors. For deeper insights into current valuation metrics, consider checking ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 3.25b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.10 > 1.0 |
| NWC/Revenue: 27.22% < 20% (prev 18.83%; Δ 8.39% < -1%) |
| CFO/TA 0.06 > 3% & CFO 2.31b > Net Income 3.25b |
| Net Debt (7.70b) to EBITDA (5.81b): 1.33 < 3 |
| Current Ratio: 1.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (539.0m) vs 12m ago -1.34% < -2% |
| Gross Margin: 39.55% > 18% (prev 0.41%; Δ 3914 % > 0.5%) |
| Asset Turnover: 64.30% > 50% (prev 61.64%; Δ 2.66% > 0%) |
| Interest Coverage Ratio: 4.96 > 6 (EBITDA TTM 5.81b / Interest Expense TTM 942.0m) |
Altman Z'' 6.35
| A: 0.18 (Total Current Assets 16.39b - Total Current Liabilities 9.60b) / Total Assets 37.73b |
| B: 1.01 (Retained Earnings 38.26b / Total Assets 37.73b) |
| C: 0.12 (EBIT TTM 4.67b / Avg Total Assets 38.80b) |
| D: 1.01 (Book Value of Equity 33.20b / Total Liabilities 32.99b) |
| Altman-Z'' Score: 6.35 = AAA |
Beneish M -2.96
| DSRI: 1.06 (Receivables 3.53b/3.27b, Revenue 24.95b/24.57b) |
| GMI: 1.04 (GM 39.55% / 41.02%) |
| AQI: 0.90 (AQ_t 0.36 / AQ_t-1 0.40) |
| SGI: 1.02 (Revenue 24.95b / 24.57b) |
| TATA: 0.03 (NI 3.25b - CFO 2.31b) / TA 37.73b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of MMM shares?
As of March 04, 2026, the stock is trading at USD 158.48 with a total of 3,467,907 shares traded.
Over the past week, the price has changed by -4.79%, over one month by +2.26%, over three months by -8.03% and over the past year by +5.20%.
Over the past week, the price has changed by -4.79%, over one month by +2.26%, over three months by -8.03% and over the past year by +5.20%.
Is MMM a buy, sell or hold?
3M has received a consensus analysts rating of 3.84.
Therefore, it is recommended to buy MMM.
- StrongBuy: 9
- Buy: 2
- Hold: 5
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the MMM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 178.2 | 12.4% |
| Analysts Target Price | 178.2 | 12.4% |
MMM Fundamental Data Overview February 28, 2026
P/E Trailing = 27.695
P/E Forward = 19.3798
P/S = 3.5082
P/B = 18.6137
P/EG = 1.6293
Revenue TTM = 24.95b USD
EBIT TTM = 4.67b USD
EBITDA TTM = 5.81b USD
Long Term Debt = 10.93b USD (from longTermDebt, last quarter)
Short Term Debt = 2.00b USD (from shortTermDebt, last quarter)
Debt = 12.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.70b USD (from netDebt column, last quarter)
Enterprise Value = 95.22b USD (87.52b + Debt 12.94b - CCE 5.24b)
Interest Coverage Ratio = 4.96 (Ebit TTM 4.67b / Interest Expense TTM 942.0m)
EV/FCF = 68.21x (Enterprise Value 95.22b / FCF TTM 1.40b)
FCF Yield = 1.47% (FCF TTM 1.40b / Enterprise Value 95.22b)
FCF Margin = 5.60% (FCF TTM 1.40b / Revenue TTM 24.95b)
Net Margin = 13.03% (Net Income TTM 3.25b / Revenue TTM 24.95b)
Gross Margin = 39.55% ((Revenue TTM 24.95b - Cost of Revenue TTM 15.08b) / Revenue TTM)
Gross Margin QoQ = 33.56% (prev 41.81%)
Tobins Q-Ratio = 2.52 (Enterprise Value 95.22b / Total Assets 37.73b)
Interest Expense / Debt = 1.72% (Interest Expense 222.0m / Debt 12.94b)
Taxrate = 24.41% (185.0m / 758.0m)
NOPAT = 3.53b (EBIT 4.67b * (1 - 24.41%))
Current Ratio = 1.71 (Total Current Assets 16.39b / Total Current Liabilities 9.60b)
Debt / Equity = 2.75 (Debt 12.94b / totalStockholderEquity, last quarter 4.70b)
Debt / EBITDA = 1.33 (Net Debt 7.70b / EBITDA 5.81b)
Debt / FCF = 5.52 (Net Debt 7.70b / FCF TTM 1.40b)
Total Stockholder Equity = 4.52b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.38% (Net Income 3.25b / Total Assets 37.73b)
RoE = 71.89% (Net Income TTM 3.25b / Total Stockholder Equity 4.52b)
RoCE = 30.23% (EBIT 4.67b / Capital Employed (Equity 4.52b + L.T.Debt 10.93b))
RoIC = 20.20% (NOPAT 3.53b / Invested Capital 17.48b)
WACC = 8.64% (E(87.52b)/V(100.46b) * Re(9.72%) + D(12.94b)/V(100.46b) * Rd(1.72%) * (1-Tc(0.24)))
Discount Rate = 9.72% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.49%
[DCF] Terminal Value 75.83% ; FCFF base≈1.09b ; Y1≈1.10b ; Y5≈1.16b
[DCF] Fair Price = 19.94 (EV 18.21b - Net Debt 7.70b = Equity 10.50b / Shares 526.7m; r=8.64% [WACC]; 5y FCF grow -0.32% → 2.90% )
EPS Correlation: -65.39 | EPS CAGR: -9.40% | SUE: 0.42 | # QB: 0
Revenue Correlation: -87.63 | Revenue CAGR: -9.26% | SUE: 0.80 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.25 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+2 | Analysts=11
EPS current Year (2026-12-31): EPS=8.66 | Chg7d=+0.000 | Chg30d=-0.006 | Revisions Net=+5 | Growth EPS=+7.5% | Growth Revenue=+3.6%
EPS next Year (2027-12-31): EPS=9.40 | Chg7d=+0.038 | Chg30d=+0.051 | Revisions Net=+8 | Growth EPS=+8.5% | Growth Revenue=+3.3%
[Analyst] Revisions Ratio: +0.33 (4 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 9.7% - Earnings Yield 3.6%)
[Growth] Growth Spread = -2.4% (Analyst 3.7% - Implied 6.1%)
P/E Forward = 19.3798
P/S = 3.5082
P/B = 18.6137
P/EG = 1.6293
Revenue TTM = 24.95b USD
EBIT TTM = 4.67b USD
EBITDA TTM = 5.81b USD
Long Term Debt = 10.93b USD (from longTermDebt, last quarter)
Short Term Debt = 2.00b USD (from shortTermDebt, last quarter)
Debt = 12.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.70b USD (from netDebt column, last quarter)
Enterprise Value = 95.22b USD (87.52b + Debt 12.94b - CCE 5.24b)
Interest Coverage Ratio = 4.96 (Ebit TTM 4.67b / Interest Expense TTM 942.0m)
EV/FCF = 68.21x (Enterprise Value 95.22b / FCF TTM 1.40b)
FCF Yield = 1.47% (FCF TTM 1.40b / Enterprise Value 95.22b)
FCF Margin = 5.60% (FCF TTM 1.40b / Revenue TTM 24.95b)
Net Margin = 13.03% (Net Income TTM 3.25b / Revenue TTM 24.95b)
Gross Margin = 39.55% ((Revenue TTM 24.95b - Cost of Revenue TTM 15.08b) / Revenue TTM)
Gross Margin QoQ = 33.56% (prev 41.81%)
Tobins Q-Ratio = 2.52 (Enterprise Value 95.22b / Total Assets 37.73b)
Interest Expense / Debt = 1.72% (Interest Expense 222.0m / Debt 12.94b)
Taxrate = 24.41% (185.0m / 758.0m)
NOPAT = 3.53b (EBIT 4.67b * (1 - 24.41%))
Current Ratio = 1.71 (Total Current Assets 16.39b / Total Current Liabilities 9.60b)
Debt / Equity = 2.75 (Debt 12.94b / totalStockholderEquity, last quarter 4.70b)
Debt / EBITDA = 1.33 (Net Debt 7.70b / EBITDA 5.81b)
Debt / FCF = 5.52 (Net Debt 7.70b / FCF TTM 1.40b)
Total Stockholder Equity = 4.52b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.38% (Net Income 3.25b / Total Assets 37.73b)
RoE = 71.89% (Net Income TTM 3.25b / Total Stockholder Equity 4.52b)
RoCE = 30.23% (EBIT 4.67b / Capital Employed (Equity 4.52b + L.T.Debt 10.93b))
RoIC = 20.20% (NOPAT 3.53b / Invested Capital 17.48b)
WACC = 8.64% (E(87.52b)/V(100.46b) * Re(9.72%) + D(12.94b)/V(100.46b) * Rd(1.72%) * (1-Tc(0.24)))
Discount Rate = 9.72% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.49%
[DCF] Terminal Value 75.83% ; FCFF base≈1.09b ; Y1≈1.10b ; Y5≈1.16b
[DCF] Fair Price = 19.94 (EV 18.21b - Net Debt 7.70b = Equity 10.50b / Shares 526.7m; r=8.64% [WACC]; 5y FCF grow -0.32% → 2.90% )
EPS Correlation: -65.39 | EPS CAGR: -9.40% | SUE: 0.42 | # QB: 0
Revenue Correlation: -87.63 | Revenue CAGR: -9.26% | SUE: 0.80 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.25 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+2 | Analysts=11
EPS current Year (2026-12-31): EPS=8.66 | Chg7d=+0.000 | Chg30d=-0.006 | Revisions Net=+5 | Growth EPS=+7.5% | Growth Revenue=+3.6%
EPS next Year (2027-12-31): EPS=9.40 | Chg7d=+0.038 | Chg30d=+0.051 | Revisions Net=+8 | Growth EPS=+8.5% | Growth Revenue=+3.3%
[Analyst] Revisions Ratio: +0.33 (4 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 9.7% - Earnings Yield 3.6%)
[Growth] Growth Spread = -2.4% (Analyst 3.7% - Implied 6.1%)